Instagram as a mental health teacher? study tests if social media can boost depression awareness in teens

NCT ID NCT07061600

Completed Knowledge-focused Sponsor: Ludwig-Maximilians - University of Munich Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether an Instagram channel called 'ich bin alles' could help teenagers learn about depression and reduce stigma. 170 teens who already used Instagram took part. The goal was to see if social media can be a good way to share mental health information and encourage young people to seek help.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Instagram-based mental health education channel
What this could lead to: If successful, this could show that social media is a useful way to teach teens about depression and encourage them to seek help.
What could go wrong: This is a completed study with 170 participants, so results are limited in size. It only tested knowledge and attitudes, not whether depression actually improves.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION - MAJOR DEPRESSIVE DISORDER DEPRESSION IN ADOLESCENCE DEPRESSIVE DISORDER

Contacts and locations

Locations

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Hospital of the Ludwig-Maximilians-University (LMU) Munich

Munich, Bavaria, 80336, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.